-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SRV2lGfIHBN2c1R1WvBM64F6v+PBnYcF9ZtYfBM/4wJiZE/3w5ruPh+tJT0cvQh3 vdjHhg7AcEClrKSRJoMghA== 0001144204-09-031494.txt : 20090608 0001144204-09-031494.hdr.sgml : 20090608 20090608164424 ACCESSION NUMBER: 0001144204-09-031494 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090608 DATE AS OF CHANGE: 20090608 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Desnick James H. CENTRAL INDEX KEY: 0001448738 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: P.O. BOX 1759 CITY: HIGHLAND PARK STATE: IL ZIP: 60035-1759 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Conmed Healthcare Management, Inc. CENTRAL INDEX KEY: 0000943324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 421297992 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-44295 FILM NUMBER: 09880025 BUSINESS ADDRESS: STREET 1: 9375 CHESAPEAKE STREET STREET 2: SUITE 203 CITY: LA PLATA, STATE: MD ZIP: 20646 BUSINESS PHONE: 5152221717 MAIL ADDRESS: STREET 1: 9375 CHESAPEAKE STREET STREET 2: SUITE 203 CITY: LA PLATA, STATE: MD ZIP: 20646 FORMER COMPANY: FORMER CONFORMED NAME: PACE HEALTH MANAGEMENT SYSTEMS INC DATE OF NAME CHANGE: 19960118 SC 13D/A 1 v151842_sc13da.htm Unassociated Document
 
Washington, D.C., 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
 
 
Conmed Healthcare Management, Inc.
(Name of Issuer)
 
Common Stock, $.0001 par value per share
(Title of Class of Securities)
 
20741M03
(CUSIP Number)
 
James H. Desnick, M.D.
Chairman of the Board
Medical Management of America, Inc.
P.O. Box 1759
Highland Park, IL 60035-1759
Telephone no. (847) 433-8307
 
 
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
June 4, 2009
(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box   ¨ .
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
 
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
 

 
 
     
1
Name of Reporting Person
 
     
 
James H. Desnick, M.D. 
 
2
Check the Appropriate Box if Member of a Group (See Instructions)
 
   
(a) o
   
(b) o
3
SEC Use Only
 
     
     
4
Source of Funds (See Instructions)
 
     
 
PF 
 
5
Check if Disclosure of Legal Proceeding isRequired Pursuant to Items 2(d) or 2(e)
 
     
   
o
6
Citizenship or Place of Reorganization
 
     
 
USA 
 
 
7
Sole Voting Power
     
   
1,209,870 
Number of
8
Shared Voting Power
Shares
   
Beneficially
   
Owned by
9
Sole Dispositive Power
Each Reporting
   
Person With
 
1,209,870 
 
10
Shared Dispositive Power
     
     
11
Aggregate Amount Beneficially Owned by Each Reporting Person
 
     
 
1,209,870 shares 
 
12
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)
 
     
   
o
13
Percent of Class Represented by Amount in Row (11)
 
     
 
9.6% 
 
14
Type of Reporting Person (See Instructions)
 
     
 
IN 
 
 
 
 

 
This Amendment No. 1 amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on October 24, 2008 (the “Statement”), relating to the shares of common stock, $.0001 par value per share (“Common Stock”), of Conmed Healthcare Management, Inc. (the “Company”) and a Warrant issued by the Company to purchase up to 91,570 shares of Common Stock (the “Warrant”), plus such additional number of shares of Common Stock as may become issuable pursuant to the “anti-dilution” provisions of the Warrant.

Item 3.
Source and Amount of Funds or Other Consideration.

Item 3 of the Statement is hereby amended and supplemented as follows:

On June 4, 2009, James H. Desnick, M.D. (“JHD”) purchased 32,000 shares of Common Stock at $3.10 per share in a private transaction.  The amount expended for such purchase by JHD was $99,200, excluding commissions and other execution related costs.
 
Item 5.
Interest in Securities of the Issuer.

Item 5 of the Statement is hereby amended and supplemented as follows:
 
JHD owns 1,118,300 shares of Common Stock, representing approximately 8.88% of the shares of Common Stock actually outstanding, and the Warrant for the purchase of up to 91,570 shares of Common Stock representing, together with the shares owned by him, approximately 9.6% of the total number of shares of Common Stock outstanding, based upon the 12,596,834 shares of Common Stock reported by the Company to be issued and outstanding as of May 14, 2009 in its Form 10-Q filed with the SEC on May 15, 2009, plus such number of shares issuable under the Warrant.
 
JHD has sole power to vote and dispose of the shares of Common Stock held by him and, after exercise of the Warrant, would have the sole power to vote and dispose of the shares of Common Stock thereby acquired.

 
 

 
 
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Dated:    June 8, 2009
/s/ James H. Desnick  
    James H. Desnick, M.D.  
 
 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----